Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Heldwein

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Nature Medicine|April 29, 2026
An agentic framework for autonomous scientific discovery in cancer pathologyFlorian Trost, Bide Zhang, Ines Aring, et al.
NPJ Precision Oncology|June 17, 2021
Cancer-specific immune evasion and substantial heterogeneity within cancer types provide evidence for personalized immunotherapyMartin Thelen, Kerstin Wennhold, Jonas Lehmann, et al.
Nature Communications|November 3, 2025
AI-powered spatial cell phenomics enhances risk stratification in non-small cell lung cancerSimon Schallenberg, Gabriel Dernbach, Sharon Ruane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2026
ADC target profiling in NSCLC: Generalizable AI separates TROP-2 and cMET phenotypesPhilipp Anders, Marvin Sextro, Katja Lingelbach, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Nature Medicine|April 29, 2026
An agentic framework for autonomous scientific discovery in cancer pathologyFlorian Trost, Bide Zhang, Ines Aring, et al.
NPJ Precision Oncology|June 17, 2021
Cancer-specific immune evasion and substantial heterogeneity within cancer types provide evidence for personalized immunotherapyMartin Thelen, Kerstin Wennhold, Jonas Lehmann, et al.
Nature Communications|November 3, 2025
AI-powered spatial cell phenomics enhances risk stratification in non-small cell lung cancerSimon Schallenberg, Gabriel Dernbach, Sharon Ruane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2026
ADC target profiling in NSCLC: Generalizable AI separates TROP-2 and cMET phenotypesPhilipp Anders, Marvin Sextro, Katja Lingelbach, et al.
Pageof 3